Professional Documents
Culture Documents
8.p0h2hjyvlr (T @) y
8.p0h2hjyvlr (T @) y
PHARMACOTHERAPEUTICS TOXICOLOGY
PHARMACOKINETICS PHARMACODYNAMICS
Pharmacotherapeutics
◦ Is the area of pharmacology that refers to the use of specific drugs to prevent, treat or
diagnose disease.
◦ Purpose: To know the effects of drugs on humans.
Pharmacokinetics
derived from the Greek words “pharmaco” (medicines/drugs) and “kinetics”
(movement).
Thus, pharmacokinetics is the study of drug movements throughout the body or the
study of how it deals with drug in terms of the way the drug is absorbed, distributed and
eliminated.
Ci - Co
◦ CL = Q --------------
Ci
Half Life
- is the time required for one half of a given amount
of drug in the body to be removed and is measured of
the rate at which the drug is eliminated from the body.
- is the amount of time requirement for 50% of the
drug remaining in the body to be eliminated.
Purpose of knowing the half-life
◦ Help determine the dosage and frequency needed
for administration of different drugs.(If a drug has a
long half life, it may need to be administered only
once a day or vise versa)
e.g. Long half-life - digoxin at 36 hrs. to be
eliminated
Short half-life - aspirin at 5 hrs. to be
administered q 4 hrs. or q 6 hrs to maintain therapeutic
effect.
Onset, Peak and Duration
Drug Actions
- are the cellular processes involved in the interaction between a
drug and cell
Drug Effects
- are the physiologic reactions of the body to the drug
Onset of Action
- is the time required for the drug to elicit a therapeutic response
Peak Effect
- is the time required for a drug to reach its maximum
therapeutic response
Duration of Action
- length of time that the drug concentration is sufficient to
elicit therapeutic response
Toxicity
- peak blood level of the drug is too high, drug become
poisonous
Mechanism of Drug Absorption
◦ Passive Diffusion/transport
◦ absorption of substances from the area of high concentration to that of low
concentration/ pressure gradient, “down-hill”
◦ doesn’t need energy to move substances
◦ Active transport/carrier-Mediated transport
◦ Involves using membrane proteins to transport substances across the cell
membrane.
◦ Transport of substance from low concentration to area of concentration, “up-hill”.
◦ Needs energy to fuel the carrier system (ATP hydrolysis)
◦ Facilitated Diffusion
◦ Bears some features of both active transport and passive diffusion.
◦ Endocytosis
◦ Drug is engulfed by the cell via an invagination of the cell
membrane.
◦ Osmosis
◦ Refers to the special case of diffusion where the diffusing
substance of water, moves from an area where it is highly
concentration to an area of low concentration.
Pharmacodynamics
“pharmaco” (drugs/medications) and “dynamics” (change)
It is the analysis of what the drug does to the body, including the
mechanism by which the drug exerts its effect.
Emulsion Oral or topical Drug mixture containing oil and water or any
other two liquids that are not mutually soluble.
Type Route Description
Gel(jelly) Topical Semisolid drug that liquefies when applied to the skin.
1. Dermatological Reactions
are adverse reactions involving the skin
These can range from simple rash to potentially fatal
exfoliative dermatitis or irritation to the skin.
Ex.
a. Rashes, Hives
b. stomatitis
Interventions:
◦ provide frequent skin care
◦ instruct the patient to avoid rubbing, tight or
rough clothing, and harsh soaps and perfume
◦ administer antihistamine
◦ In severe cases, discontinue the drug and
notify the care provider
Intervention:
◦provide frequent mouth care with nonirritating
solution.
◦For nutrition, provide a small but frequent
meals.
2. Superinfections
- due to destruction of the normal flora of
the body.
assessment:
fever
diarrhea
black or hairy tongue
inflamed and swollen tongue
mucous membrane lesion
vaginal discharge with or without itching
Interventions:
frequent mouth care
skin care
access to bathroom facilities
small and frequent diet
In severe cases, discontinue the drug
3. Blood dyscrasia
– is a bone marrow suppression caused by
a drug effects.
◦This occurs when drugs that can cause cell
death (e.g. antineoplastics, antibiotics) are
used
assessment:
fever
chills
sore throats
weakness
back pain
dark urine
decrease hematocrit
low platelet count
low white blood cells
Interventions:
◦monitor blood count
◦protection from exposure to infection
◦protection from injury
◦avoidance of activities that might result in injury
and bleeding
4. Toxicity
◦ Liver injury
assessment:
fever
malaise
nausea
vomiting
jaundice
change in color of urine or stools
abdominal pain or colic
elevated liver enzymes
alteration in bilirubin levels
changes in clotting factors
Interventions:
discontinue the drug and notify the prescriber
Offer supportive measures
5. Renal injury
assessment:
elevated blood urea nitrogen
elevated creatinine concentration
decrease hematocrit
electrolyt imbalances
fatigue
malaise
edema
irritability
◦Interventions:
◦ discontinue drug, notify the prescriber
◦ in severe cases, dialysis maybe required
6. Poisoning
occurs when an overdose of a drug
damages multiple body systems, leading to
potential for fatal reactions.
Alteration in glucose metabolism
◦Hypoglycemia
assessment:
Fatigue
drowsiness
Hunger
anxiety
headache
cold and clammy skin
shaking and lack of coordination.
Increase heart rate, blood pressure,
numbness and tingling of the mouth, tongue
and lips,
confusion, rapid and shallow respiration.
In severe cases seizure and or coma may
occur. *
◦ Interventions:
◦restore glucose intravenously
◦institute safety measure to prevent injury or falls
◦Hyperglycemia:
assessment:
fatigue
increase urination
increase thirst
deep respiration
restlessness
increase hunger
nausea
fruity odor to breath
◦ Interventions:
◦ administer insulin therapy
◦ Provide support to help the patient deal with signs and
symptoms